In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-γ T cell response

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Sauzullo, Ilaria ^a   Mengoni, Fabio ^a   Lichtner, Miriam ^a   Massetti, Anna Paola ^a   Rossi, Raffaella ^a   Iannetta, Marco ^a   Marocco, Raffaella ^a   Del Borgo, Cosmo ^b   Soscia, Fabrizio ^b   Vullo, Vincenzo ^a   Mastroianni, Claudio Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SANTA MARIA GORETTI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; ETHAMBUTOL; GAMMA INTERFERON; ISONIAZID; MYCOBACTERIUM ANTIGEN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; BACTERIAL ANTIGEN; MYCOBACTERIUM TUBERCULOSIS ANTIGENS;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ACTIVITY; DRUG EFFICACY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; T LYMPHOCYTE; TUBERCULOSIS; IMMUNOLOGY; SECRETION;

MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; YOUNG ADULT;

EID: 65249095474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005187     Document Type: Article

References (40)

1. Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761-76.
2. Richeldi L (2006) An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 174: 736-42.
3. Lalvani A (2007) Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 13: 1898-906.
4. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R (2007) T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 7: 428-38.
5. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-144.
6. Lalvani A, Pathan AA, Durkan H, et al. (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357: 2017-21.
7. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, et al. (2001) Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163: 824-8.
8. Mazurek GH, LoBue PA, Daley CL, et al. (2001) Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 286: 1740-7.
9. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, et al. (2003) Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361: 1168-73.
10. Hussain R, Kaleem A, Shahid F, et al. (2002) Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 264(1-2): 95-108.
11. Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, et al. (2007) Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis 11: 1190-5.
12. Kobashi Y, Obase Y, Fukuda M, et al. (2007) Usefulness of Quanti-FERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers. Intern Med 46: 1543-9.
13. Manuel O, Humar A, Preiksaitis J, et al. (2007) Comparison of Quanti-FERON-TB Gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 7: 2797-801.
14. Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, et al. (2007) Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 175: 618-27.
15. Pathan AA, Wilkinson KA, Klenerman P, et al. (2001) Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4+ T cells in Mycobacterium tuberculosis-infected individuals: association with clinical disease state and effect of treatment. J Immunol 167: 5217-25.
16. Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, et al. (2001) Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183: 469-77.
17. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, et al. (2004) Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 38: 754-6.
18. Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah DJ, et al. (2006) Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 6: 66.
19. Dheda K, Pooran A, Pai M, et al. (2007) Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. J Infect 55: 169-73.
20. Ulrichs T, Anding R, Kaufmann SH, Munk ME (2000) Numbers of IFN gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int J Tuberc Lung Dis 4: 1181-3.
21. Wu-Hsieh BA, Chen CK, Chang JH, Lai SY, Wu CH, et al. (2001) Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis 33: 1336-40.
22. Vekemans J, Lienhardt C, Sillah JS, Wheeler JG, Lahai GP, et al. (2001) Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 69: 6554-7.
23. Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P (2003) Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 38: 249-56.
24. Ferrand RA, Bothamley GH, Whelan A, Dockrell HM (2005) Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after antituberculosis treatment. Int J Tuberc Lung Dis 9: 1034-9.
25. Pai M, Joshi R, Bandyopadhyay M, et al. (2007) Sensitivity of a whole blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during antituberculosis treatment. Infection 35: 98-103.
26. Sallusto F, Lenig D, Forster R, Lippi M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-12.
27. Lalvani A (2004) Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis 38: 757-9.
28. Leyten EM, Mulder B, Prins C, et al. (2006) Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis-specific peptides for diagnosis of recent infection with M tuberculosis after accidental laboratory exposure. J Clin Microbiol 44: 1197-1201.
29. Sprent J, Surh CD (2002) T cell memory. Annu Rev Immunol 20: 551-79.
30. Kaech SM, Wherry EJ, Ahmed R (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2: 251-62.
31. Sauzullo I, Mengoni F, Lichtner M, et al. (2008) QuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis. Diagn Microbiol Infect Dis 62: 395-401.
32. Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H (2008) Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 12: 1146-52.
33. Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, et al. (2007) Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 14: 880-5.
34. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, et al. (2008) Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J Infect, (in press) doi:10.1016/j.jinf.2008.08.009.
35. Domínguez J, Souza-Galvão MD, Ruiz-Manzano J, et al. (2008) T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagn Microbiol Infect Dis, (in press) doi:10.1016/j.diagmicrobio.2008.09.010.
36. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, et al. (2006) Serial testing of health care workers for tuberculosis using interferon-gamma assay. AmJ Respir Crit Care Med 174: 349-55.
37. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, et al. (2007) Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PloS Med 4(6): e192.
38. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, et al. (2006) Dynamic antigen specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174: 831-9.
39. Hill PC, Jeffries DJ, Brookes RH, Fox A, Jackson-Sillah D, et al. (2007) Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PloS ONE 2(1): e183.
40. Corbett EL, Kathryn C, Millington KA, Ewer K, Cheung YY, et al. (2006) Tuberculosis infection in African nursing students: Tuberculin skin test compared to ELISPOT conversion rates. Int J Tuberc Lung Dis 10: S231.